loadpatents
name:-0.028398036956787
name:-0.0028290748596191
name:-0.023370981216431
GERRING; David Patent Filings

GERRING; David

Patent Applications and Registrations

Patent applications and USPTO patent grants for GERRING; David.The latest application filed is for "novel composition comprising antibodies".

Company Profile
19.2.27
  • GERRING; David - Little Chesterford Saffron Walden
  • GERRING; David - Saffron Walden GB
  • GERRING; David - Cambridge GB
  • GERRING; David - Haslingfield Cambridge
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Novel Composition Comprising Antibodies
App 20220288165 - JEZEK; Jan ;   et al.
2022-09-15
Aqueous Solution Compositions For Increasing Stability Of Engineered Dimeric Proteins
App 20220265788 - JEZEK; Jan ;   et al.
2022-08-25
Novel Formulations
App 20220184213 - GERRING; David ;   et al.
2022-06-16
Liquid Pharmaceutical Composition
App 20220175924 - JEZEK; Jan ;   et al.
2022-06-09
STABILIZED Fc FUSION PROTEIN SOLUTIONS
App 20220125718 - JEZEK; Jan ;   et al.
2022-04-28
Liquid pharmaceutical composition
Grant 11,291,725 - Jezek , et al. April 5, 2
2022-04-05
Formulations
Grant 11,278,624 - Gerring , et al. March 22, 2
2022-03-22
Novel Composition
App 20220080023 - JEZEK; Jan ;   et al.
2022-03-17
Novel Composition
App 20220072090 - JEZEK; Jan ;   et al.
2022-03-10
Novel Composition
App 20220072091 - JEZEK; Jan ;   et al.
2022-03-10
Medical Infusion Pump System For The Delivery Of An Insulin Compound
App 20210113763 - JEZEK; Jan ;   et al.
2021-04-22
Medical Infusion Pump System For The Delivery Of An Insulin Compound
App 20210093775 - JEZEK; Jan ;   et al.
2021-04-01
Novel Composition
App 20210085751 - JEZEK; Jan ;   et al.
2021-03-25
Medical Infusion Pump System For The Delivery Of An Insulin Compound
App 20210038506 - JEZEK; Jan ;   et al.
2021-02-11
Glucagon-like Peptide 1 (glp-1) Receptor Agonist Compositions
App 20200222508 - JEZEK; Jan ;   et al.
2020-07-16
Novel Formulations
App 20200093894 - JEZEK; Jan ;   et al.
2020-03-26
Stable Insulin Formulations
App 20200093895 - JEZEK; Jan ;   et al.
2020-03-26
Stabilized Antibody Protein Solutions
App 20200069799 - JEZEK; Jan ;   et al.
2020-03-05
Stabilized Antibody Protein Solutions
App 20200071352 - JEZEK; Jan ;   et al.
2020-03-05
Stabilized Antibody Solutions
App 20200023061 - JEZEK; Jan ;   et al.
2020-01-23
Stabilized Antibody Protein Solutions
App 20200023062 - JEZEK; Jan ;   et al.
2020-01-23
Liquid Pharmaceutical Composition
App 20200016075 - BADIALI; Luca ;   et al.
2020-01-16
Liquid Pharmaceutical Composition
App 20200016074 - BADIALI; Luca ;   et al.
2020-01-16
Novel Formulations
App 20190290737 - GERRING; David ;   et al.
2019-09-26
Novel Formulations
App 20190282667 - GERRING; David ;   et al.
2019-09-19
Liquid Pharmaceutical Composition
App 20190262450 - JEZEK; Jan ;   et al.
2019-08-29
Insulin Glargine
App 20190183980 - GERRING; David ;   et al.
2019-06-20
Insulin Glargine And Triethylenetetramine (teta)
App 20190175737 - JEZEK; Jan ;   et al.
2019-06-13
Novel Formulations
App 20180078645 - GERRING; David ;   et al.
2018-03-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed